MTMR8

MTMR8 is an active myotubularin-family lipid 3-phosphatase that preferentially dephosphorylates PtdIns(3)P and, together with the catalytically inactive family member MTMR9, controls phosphoinositide pools governing autophagy, membrane trafficking, and actin-dependent development (PMID:22647598, PMID:26143924). MTMR8 forms a stable heteromeric complex with MTMR9, and this partnership amplifies its catalytic output—enhancing activity ~4-fold toward PtdIns(3)P and shifting the complex's substrate preference toward PtdIns(3)P—so that the complex lowers cellular PtdIns(3)P and inhibits autophagy (PMID:16787938, PMID:22647598). Consistent with this, loss of MTMR8 function causes autophagic vesicle accumulation and perturbs endolysosomal homeostasis, establishing it as a regulator of autophagic flux (PMID:32915229). The crystal structure of its phosphatase domain reveals a novel dimerization mode with twofold symmetry, a Lys255 contact with the substrate diacylglycerol moiety, and reversible oxidation-dependent inactivation of the catalytic Cys338 via a non-disulfide oxidation-protective intermediate (PMID:26143924). Through MTMR9, which localizes to the intermediate compartment and Golgi, MTMR8 is recruited to these compartments where the complex co-localizes with and regulates RAB1A, linking it to ER-to-Golgi trafficking (PMID:31704058). In zebrafish, Mtmr8 represses PI3K/Akt signaling to organize the actin cytoskeleton during somitogenesis and muscle development, and to specify arterial endothelial identity through a Hedgehog/PI3K/VEGF cascade (PMID:19325702, PMID:20815916).

1. 2006 High

   Established that MTMR8 does not act alone but physically partners with another myotubularin, identifying MTMR9 as a heteromeric complex partner and framing MTMR8 function as complex-dependent.

   Evidence Yeast two-hybrid and reciprocal co-immunoprecipitation of epitope-tagged proteins

   PMID:16787938

   Open questions at the time

   • Did not define the catalytic or functional consequence of the interaction
   • No stoichiometry or interface mapping
2. 2009 Medium

   Provided the first in vivo functional role, showing MTMR8 organizes the actin cytoskeleton and muscle development by restraining PI3K/Akt signaling, with the PH/G domain required for function.

   Evidence Morpholino knockdown in zebrafish with domain-deletion, PI3K inhibitor treatment, phospho-Akt western blot, and cell transplantation

   PMID:19325702

   Open questions at the time

   • Morpholino-based; mechanism connecting lipid phosphatase activity to actin not biochemically resolved
   • Non-cell-autonomous effector unidentified
3. 2010 Medium

   Extended the developmental role to vascular patterning, showing MTMR8 represses PI3K to specify arterial endothelial identity within a Hedgehog/PI3K/VEGF cascade.

   Evidence Morpholino knockdown in zebrafish with pharmacological and mRNA rescue and arterial marker analysis

   PMID:20815916

   Open questions at the time

   • Morpholino-based; direct phosphoinositide substrate in endothelium not measured
   • Epistatic placement within Hedgehog/PI3K/VEGF inferred from rescue, not direct interaction
4. 2012 High

   Resolved the biochemical basis of the MTMR8–MTMR9 partnership, demonstrating MTMR9 dimerization boosts MTMR8 phosphatase activity, biases the complex toward PtdIns(3)P, and lowers cellular PtdIns(3)P to inhibit autophagy.

   Evidence In vitro phosphatase assays with purified MTMR8/MTMR9 complexes, substrate specificity measurements, cellular PtdIns(3)P quantification, and autophagy assays

   PMID:22647598

   Open questions at the time

   • Structural basis of activation not defined here
   • In vivo substrate site in cells not directly identified
5. 2015 High

   Defined the structural and regulatory architecture of the catalytic domain, revealing a novel dimerization mode, a Lys255 substrate contact, and reversible redox control of the catalytic Cys338.

   Evidence X-ray crystallography of the phosphatase domain with mutagenesis and redox activity assays

   PMID:26143924

   Open questions at the time

   • Structure of the MTMR8–MTMR9 heterocomplex not solved
   • Identity of the oxidation-protective intermediate at Cys338 unresolved
   • Physiological trigger of redox regulation unknown
6. 2019 Medium

   Connected the complex to a new membrane-trafficking arena, showing MTMR9 recruits MTMR8 to the intermediate compartment/Golgi where the complex regulates RAB1A and ER-to-Golgi transport.

   Evidence Fluorescence co-localization, MTMR9 loss/gain-of-function, RAB1A localization assays, and secretion assays

   PMID:31704058

   Open questions at the time

   • Whether RAB1A regulation depends on MTMR8 catalytic activity not established
   • Single lab; mechanism linking PtdIns(3)P turnover to RAB1A localization unclear
7. 2020 Medium

   Consolidated the autophagy role in higher-animal cells, showing reduced MTMR8 function drives autophagic vesicle accumulation and disrupts endolysosomal homeostasis, marking it a regulator of autophagic flux.

   Evidence Loss-of-function studies in cell lines with autophagic and endolysosomal markers, corroborated by Drosophila ortholog data

   PMID:32915229

   Open questions at the time

   • Step in the autophagy pathway directly controlled not pinpointed
   • Dependence on MTMR9 partnership in this context not tested

• How MTMR8's catalytic regulation, trafficking, and developmental signaling roles are mechanistically unified—and whether redox control of Cys338 operates physiologically—remains unresolved.
• No structure of the active MTMR8–MTMR9 heterocomplex
• Direct effector linking PtdIns(3)P turnover to actin and arterial specification not identified
• Physiological context of redox inactivation unknown